Revolka builds its business around proprietary aiProtein® technology — advancing in-house drug discovery and partnership services to create new value for industry and society through innovations in protein engineering.
Business Built Around aiProtein®
With aiProtein® technology at the core, our two business pillars work in synergy. Insights gained through partnerships are applied to our in-house drug discovery, and collaborative research opens up new fields of application — forming an integrated ecosystem for innovation.
Pharmaceutical Business
Overcoming the Challenges of Protein Replacement Therapy
Using proprietary designs powered by aiProtein® technology, we are developing an in-house drug discovery pipeline targeting inherited metabolic disorders.
Partnership Business
Accelerating R&D for Companies and Research Institutions Worldwide
We optimize antibody and enzyme functions for pharmaceutical, chemical, and other companies as well as research institutions around the world using aiProtein®. By designing high-performance proteins quickly and cost-effectively, we improve R&D efficiency and increase the probability of success.
Application Examples
-
Antibody Therapeutics
- Enhanced affinity and specificity
- Improved stability
-
Industrial Enzymes
- Improved reaction efficiency
- Enhanced thermostability and pH tolerance
-
Diagnostics
- Enhanced sensitivity and specificity
- Improved storage stability
-
Food Enzymes
- Enhanced functionality
- Ensured safety
-
Environmental Remediation
- Enhanced degradation capacity
- Introduction of novel functions
-
Agricultural Biotechnology
- Improved pest and disease resistance
- Enhanced productivity
